PALVELLA THERAPEUTICS, INC. ($PVLA)
Filing Information
| Accession Number | 0001104659-26-032695 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 20, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
12,906
Total Value
$542,494.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 18, 2026 | Exercise/Conversion | 2,154 | $7.14 | $15,379.56 | 2,154 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 18, 2026 | Exercise/Conversion | 2,148 | $9.08 | $19,503.84 | 4,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 18, 2026 | Sale | 2,268 | $117.56 | $266,633.34 | 2,034 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 18, 2026 | Sale | 1,730 | $118.37 | $204,776.81 | 304 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 18, 2026 | Sale | 304 | $119.08 | $36,200.84 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 18, 2026 | Exercise/Conversion | 2,154 | $0.00 | $0.00 | 15,089 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 18, 2026 | Exercise/Conversion | 2,148 | $0.00 | $0.00 | 15,036 | Direct | โ | View Details |